newsfilter
← Latest News
GlobeNewswire·

Ernexa Therapeutics Closes New Funding Round

CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has